The potential value of fatty acid binding protein 1 in Chronic HBV-related liver disease progression assessment
Our study demonstrated a significant inverse correlation between FABP1 levels and the severity of inflammation grades in patients with HBV-related liver diseases. Furthermore, elevated serum FABP1 levels were observed in these patients, suggesting its potential as a biomarker for assessing HBV-related liver damage to initiate antiviral therapy. Additionally, further evaluation is required to determine its potential as a biomarker for assessing disease severity.
Authors
- Bingliang Lin (ORCID: https://orcid.org/0000-0003-4069-6287)
- Chao Wu (ORCID: https://orcid.org/0000-0002-1657-010X)
- Shasha Ma (ORCID: https://orcid.org/0000-0003-4858-8715)
- Lubiao Chen (ORCID: https://orcid.org/0000-0002-6451-4022)
- Zhaoxia Hu (ORCID: https://orcid.org/0000-0002-9486-4461)
- Mingna Li (ORCID: https://orcid.org/0000-0002-4658-9063)
- Kuerbannisa Wulayin
- Maimaitiaili Tuerxun
- Xiaoyan Li (ORCID: https://orcid.org/0000-0001-7166-0135)
- Lian Zhou (ORCID: https://orcid.org/0000-0003-1790-4500)
- Shutao Lin
Institutions
- Sun Yat-sen University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Affiliated Hospital of Youjiang Medical University for Nationalities (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- Kashi University (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1186/s12879-024-10114-8
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00